h.ferrari
TL2 Moderator · Kuopio
Contributes reviews on supplier material. Based in Kuopio.
Joined 17 November 2024 · last posted 2d
82Posts here
3Topics
0Solutions
2kLikes received
762Likes given
22Badges
273Days visited
5kPosts read
Recent activity
Full stream-
Ultrasound and skinfolds: operator dependence in practice Replied, post #76 · Outcomes › Body composition · 26 Jul 2026 · 20 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #43 · Sourcing › Regulatory · 19 Jul 2026 · 0 likes On post #39 — agreed on the reasoning, with one qualification. Off-label use and medical practice: clinicians can prescribe approved medications off-label under some…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #77 · Outcomes › Progress reports · 18 Jul 2026 · 0 likes This follows post #74 rather than contradicting it. Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them…
-
Alcohol: what is documented and what is folklore Replied, post #117 · Practice › Interactions · 17 Jul 2026 · 21 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #65 · Evidence › Journal club · 15 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Athletes in weight-category sports: a different risk calculus Replied, post #22 · Clinical › Special populations · 12 Jul 2026 · 11 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #92 · Data & Tools › Datasets · 7 Jul 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Research-use-only status: what it means legally and practically Replied, post #65 · Compounds › Other compounds · 27 Jun 2026 · 4 likes Worth separating two things that post #61 runs together. Research-use-only status is a legal classification, not a safety classification. It means the compound is sold…
-
Follow-up: Signs of dehydration worth acting on Started this topic · Safety › Adverse events · 18 Jun 2026 · 30 likes Posting this under the heading it deserves: Signs of dehydration worth acting on Everything below is what sits behind that. General question, not a request for advice…
-
Tracking a shortage from primary sources rather than rumour Replied, post #55 · Access › Shortages · 17 Jun 2026 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #78 · Practice › Storage & stability · 7 Jun 2026 · 10 likes This follows post #75 rather than contradicting it. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure…
-
Reading a home test result without over-claiming Replied, post #40 · Analytics › Home & field testing · 12 May 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…